SequelSEC

PHIBRO ANIMAL HEALTH CORP PAHC

Pharmaceutical Preparations · CIK 0001069899 · Fiscal year ends 0630

AnnualQuarterlyTTM
Revenue
$1.52B
Fiscal year ended 2026-06-30
Operating income
$194.40M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

PHIBRO ANIMAL HEALTH CORP (PAHC) reported revenue of $1.52B and net income of $99.72M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from PHIBRO ANIMAL HEALTH CORP’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

PHIBRO ANIMAL HEALTH CORP income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$1.52B
Cost of revenue$1.01B
Gross profit$512.52M
Operating income$194.40M
Net income$99.72M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income$137.35M
Income tax expense$37.63M
Diluted EPSUnavailable
Selling, general & administrative$318.12M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

PHIBRO ANIMAL HEALTH CORP balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$61.42M
Total assets$1.50B
Current assets$935.51M
Total liabilities$1.12B
Current liabilities$316.47M
Total equity incl. NCI$385.48M
Temporary (mezzanine) equityUnavailable
Inventory$534.88M
Accounts receivable$238.79M
Goodwill$60.04M
Long-term debtUnavailable
Accounts payable$127.31M

Cash flow

PHIBRO ANIMAL HEALTH CORP cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$68.95M
Capital expendituresUnavailable
Investing cash flow-$71.46M
Financing cash flow-$6.56M
Net change in cash-$6.62M
Stock-based compensation$1.60M
Common dividends paid$19.46M
Common share repurchasesUnavailable
Depreciation & amortization$51.51M

Derived

PHIBRO ANIMAL HEALTH CORP derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin33.8%
Operating margin12.8%
FCF marginUnavailable
SBC / revenue0.1%
Current ratio2.96x
Revenue YoY growth17.1%
Net margin6.6%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rate27.4%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PAHC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-K · Filed 2026-08-26View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-Q · Filed 2026-02-04View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-K · Filed 2025-08-27View SEC filing
10-Q · Filed 2025-05-07View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.